Skip to content

New circumcision standardized application and reproductive health effects, a large multi-center clinical trial

New circumcision standardized application and reproductive health effects, a large multi-center clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003428
Enrollment
Unknown
Registered
2013-06-13
Start date
2013-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

redundant prepuce, phimosis

Interventions

Experimental group:Circumcision using the disposable circumcision stapler

Sponsors

The First Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. male, redundant prepuce or phimosisage from 18 to 60 years old; 2. No abnormalities for blood, coagulation and urine routine examination; 3. Obey the rules and follow the procedures, understand the research, willing to participate in the study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Foreskin / glans infection, edema, hypospadias, priapism, epispadias, penile torsion, concealed penis, webbed penis, small penis, urethra hypoplasia, hermaphroditism, suspected penile cancer; 2. Systemic disease (bleeding tendency, severe cardiovascular disease, diabetes); 3. Skin or connective tissue diseases which may affect wound healing.

Design outcomes

Primary

MeasureTime frame
operation time;The amount of bleeding;Postoperative pain scores;Wound healing time;The incidence of complications;The appearance satisfaction rate;The evaluation of sexual satisfaction;

Secondary

MeasureTime frame
Reproductive health indicators (HIV, HPV, HSV, syphilis);

Countries

China

Contacts

Public ContactChunhua Deng
dch0313@163.com+86 13501519349

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026